REFG Financials Monday, July 14, 2014 11:22:56 PM
Post# of 227
Medical Cannabis Payment Solutions
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. - 108 29 134
Non-Recurring Items - - - -
Other - - - -
Operating Income - (108) (29) (134)
Income From Continuing Operations
Add'l Income/Expense Items - - - (2,800)
Earnings Before Interest and Tax - (108) (29) (2,934)
Interest Expense - 6 - -
Earnings Before Tax - (114) (29) (2,934)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations - (114) (29) (2,934)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income - (114) (29) (2,934)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders - (114) (29) (2,934)